The global CD20 monoclonal antibodies market is witnessing strong and sustained growth, driven by the rising prevalence of autoimmune diseases and B-cell malignancies, along with rapid advancements in biologic drug development. CD20 monoclonal antibodies are targeted immunotherapies that bind to the CD20 antigen expressed on B lymphocytes, enabling effective treatment of conditions...

The Global CD20 Monoclonal Antibodies Market is a pivotal segment of therapeutic biologics focused on treating CD20-positive hematological cancers and autoimmune diseases. CD20 monoclonal antibodies are engineered proteins that selectively target the CD20 antigen found on the surface of B-cells, enabling immune-mediated destruction of malignant or dysregulated cells. These therapies...